Recent advances in human proteomics and transcriptomics have led to identification of tissue-specific genes that confer molecular identity to individual tissues, as highlighted by the Human Protein Atlas Project, which combines tissue-specific proteome data with global gene expression analysis for more than 40 human tissues. 1 These data sets allow examination of the contribution of tissue-specific genes to disease pathogenesis, constituting a novel tissue-centered approach for diagnostics and potentially for predictive purposes.
Eosinophilic esophagitis (EoE) is a chronic allergic inflammatory disease characterized by eosinophil-predominant, tissuespecific mucosal inflammation. The disease is mediated in large part by an immune response to food allergens. This immune response involves the interaction of innate immunity (epithelium and eosinophils) with a strong T H 2-adaptive immune response characterized by IL-13 overproduction, resulting in marked alteration in esophageal gene expression. Notably, IL-13 directly stimulates the epithelium to produce a large subset of the EoE-associated transcriptome, including the eosinophil chemoattractant and activating factor CCL26 (eotaxin-3), thus propagating the inflammatory loop. Esophageal tissue integrity has a critical role in disease pathogenesis, [4] [5] [6] [7] [8] [9] as illustrated by profound dysregulation of the epidermal differentiation complex (EDC) genes 10 and decreased expression of desmoglein 1 (DSG1) in patients with active EoE and IL-13-stimulated esophageal epithelial cells. 4 In line with these findings, genes for structural proteins, including keratin 6C (KRT6C), KRT32, and the EDC gene cornulin (CRNN), are among the most highly expressed genes in the homeostatic esophagus based on the Human Protein Atlas. Recent genome-wide association study (GWAS) analyses identified the cysteine protease calpain 14 (CAPN14), another highly expressed gene in the homeostatic esophagus, as one of the strongest genetic risk factors associated with disease susceptibility, 11, 12 suggesting that protease activity is critical for disease pathophysiology. Indeed, both CAPN14 and serine peptidase inhibitor B13 (SERPINB13) were upregulated in biopsy specimens from patients with EoE, and dysregulation of CAPN14 in esophageal epithelial cells resulted in impaired barrier function of differentiated epithelium. 13 Here we interrogated changes in the esophagus-specific transcriptome defined by the Human Protein Atlas (297 genes expressed >5-fold higher in the esophagus vs any other human tissue 1 ) in patients with EoE. We identified 117 esophagus-specific genes that were significantly dysregulated in patients with EoE. Remarkably, approximately 90% of these genes were downregulated, demonstrating a profound loss of esophageal tissue gene signature in the allergic inflamed esophagus. Functional analysis of the esophagus-specific genes altered in patients with EoE revealed loss of esophageal differentiation, identified proteolytic activity as a central pathway impaired in the diseased esophagus, and implicated genes from the SERPIN and IL-1 families as those most significantly affected of the tissue-specific genes in patients with EoE. Quantification of IL-36a, SERPINB13, SERPINB4, and CRNN proteins in control and inflamed esophageal biopsy specimens corroborated transcriptional data. Transcriptional changes observed in the inflamed esophagus were largely reproduced in esophageal cells treated with IL-13 in vitro, which showed an impaired epithelial cell differentiation program. Whole-exome sequencing (WES) analysis of 33 unrelated patients with EoE identified 39 rare mutations in 18 esophagus-specific genes that were transcriptionally altered in the disease. Functional enrichment analysis identified proteolytic activity and tissue differentiation as the most significant pathways associated with these genes. These data substantiate a potential functional link between the esophageal transcriptome and EoE pathogenesis. Collectively, our study reveals profound loss of esophageal epithelial differentiation as a hallmark of EoE and implicates proteaseand IL-1-related activities as putative, key, tissue-specific pathways involved in the disease. We propose that loss of the esophagus-specific molecular signature in patients with EoE is a disease-specific process that has potential value for predictive medicine, diagnostics, and treatment of this disease.
METHODS

Gene definitions
Definitions related to specificity of expression in the esophagus were from the Human Protein Atlas (http://www.proteinatlas.org/humanproteome/ esophagus; Accessed May 2016). Tissue-enriched genes are expressed in the esophagus at levels at least 5-fold higher than those in any other tissue transcriptionally profiled by the Human Protein Atlas, group-enriched genes are expressed at levels at least 5-fold higher in the group of 2 to 7 tissues, and tissue-enhanced genes are expressed at levels at least 5-fold higher in the esophagus compared with the average of expression in all tissues. Post acceptance updates to the Human Protein Atlas may alter the number of tissue-specific (and esophagus-specific) genes from values presented herein.
Expression data and WES
Publically available expression data were used for esophageal biopsy specimens of patients with EoE or control subjects (GSE58640), 3 antrum biopsy specimens of patients with eosinophilic gastritis (EG) or control subjects (GSE54043), 14 TE-7 cells (GSE57637), 15 and EPC2 air-liquid interface (ALI) cultures (GSE58640 and GSE65335). 16 There was no statistical difference (P 5 .26, Mann-Whitney U test) in age between patients in the EoE and control groups used for RNA sequencing analysis. 3 Lists of esophagus-and stomachspecific genes were obtained from the Human Protein Atlas (http://www. proteinatlas.org). Gene ontology enrichment analysis, which uses statistical methods to determine functional pathways and cellular processes associated with a given set of genes, was performed with the ToppGene suite (https:// toppgene.cchmc.org/ 17 ); Venny (http://bioinfogp.cnb.csic.es/tools/venny/ index.html) was used to intersect gene lists; Cluster 3.0 was applied for clustering genes using Euclidean distance and average linking parameters; and Java TreeView was used for visualization of heat maps (http://bonsai.hgc.jp/ ;mdehoon/software/cluster/software.htm). WES analysis was performed and analyzed as in Patel et al. 18 Briefly, only variant calls with a read depth of greater than 15 and a genotype quality score of greater than 20 were included. In addition, variants were removed that had a minor allele frequency of greater than 1% in the general population (based on the 1000 Genomes Project, http://www.1000genomes.org/) or the National Heart, Lung, and Blood Institute Exome Sequencing Project (https://esp.gs.washington.edu) and were required to alter the amino acid sequence of the protein.
ALI culture system
The ALI differentiation protocol was performed essentially as previously described. 4, 16 Briefly, EPC2 immortalized esophageal epithelial cells were seeded onto semipermeable membranes (0.4 mm) and grown to confluence in standard low-calcium medium (keratinocyte serum-free medium with pituitary extract and epidermal growth factor at 1 ng/mL, 0.09 mmol/L calcium concentration). Epithelial differentiation was induced by addition of keratinocyte serum-free medium with high calcium (1.8 mmol/L final concentration) over the course of 5 days (initial differentiation). Medium was replaced in both chambers every other day. Stratification was induced by removing media from the upper chamber and exposing the cells to the air interface for a period of 5 to 6 days (terminal differentiation). Cells remained exposed to high-calcium medium in the bottom chamber throughout terminal differentiation. Treatment with IL-13 (100 ng/mL) in the lower chamber started at the first day of exposure to the air interface (day 8), with fresh media with IL-13 added every other day. In some experiments cultures were treated with IL-1a (10 ng/mL) for the last 2 days of ALI culture. At the last day of ALI culture, cells were collected for analysis.
Immunofluorescence analysis
Immunofluorescence staining was performed, as previously described, 4 on at least 4 distal esophageal biopsy specimens from control subjects, distal esophageal biopsy specimens with active inflammation from patients with active EoE, or proximal esophageal biopsy specimens without active inflammation from the same patients with active EoE. The average ages of patients with EoE and control subjects were 13 and 11 years, respectively. Patient groups were also controlled for race and sex. 3 B, Venn diagram shows overlap of genes specifically expressed in the esophagus according to the Human Protein Atlas (Esophagus) with genes differentially expressed in the esophageal tissue of patients with active EoE compared with control esophageal tissue (EoE). For each group of genes (see the text and the Methods section for definitions), the number of upregulated (Up) and downregulated (Down) genes is shown (not to scale). A set of 117 overlapping genes is designated as Eso-EoE genes. C, Normalized expression levels for each gene (fragments per kilobase per million reads [FPKM]) in esophageal biopsy tissue from patients with active EoE (EoE, blue rectangles, n 5 10) and control subjects (Ctrl, green rectangles, n 5 6) for the 12 genes most highly expressed in the homeostatic esophagus are presented as a box-and-whiskers plot. Genes upregulated in samples from patients with active EoE are in orange. The P value for each gene is shown on the right. Statistical significance was determined by using the Holm-Sidak method. D, Venn diagram shows the overlap of genes specifically expressed in the stomach according to the Human Protein Atlas with genes differentially expressed in biopsy specimens of patients with EG. 
Protein Domain
Functional enrichment analysis of esophagus-specific Eso-EoE genes altered in patients with EoE. Shown are the 10 most significant terms identified for Eso-EoE genes by functional enrichment analysis in the following categories: Molecular Function (A), Biological Processes (B), Human Phenotype (C), and Protein Domain (D). Genes for the selected terms (gray bars) are listed with the corresponding fold change in expression for active EoE (EoE) compared with control (Ctrl) samples. Upregulated genes are in orange. The x-axes represent the negative log 10 P value.
were used at a final concentration of 1 mg/mL: anti-KRT14 (PRB-155P; Covance, Princeton, NJ), anti-KRT5 (ab24647; Abcam, Cambridge, United Kingdom), anti-KRT4 (HPA034881, Sigma), or anti-CRNN (AF3607, R&D Systems). Nuclei were stained with 49,6-diamidino-2-phenylindole (DAPI). Slides were blocked with PBS with 10% goat or donkey serum. Secondary antibodies (1:500 dilution) used were donkey anti-rabbit Alexa Fluor 647 (A31573; Life Technologies, Grand Island, NY), goat anti-rabbit Alexa Fluor 647 (A21244, Life Technologies), or donkey anti-goat Alexa Fluor 488 (A11055, Life Technologies). Imaging was performed with a Nikon A1 inverted confocal microscope (Nikon, Tokyo, Japan).
RESULTS
Specific loss of esophageal signature genes in patients with EoE
To test the hypothesis that esophagus-specific genes contribute to EoE pathogenesis, we intersected genes transcriptionally altered in patients with EoE 3 with various organ-specific transcriptomes obtained from the Human Protein Atlas, including the esophagus, salivary gland, gastrointestinal tract organs, kidney, lung, skin, and testis. Genes in the transcriptomes are classified as tissue enriched (> _5-fold higher expression in the interrogated tissue than in any other tissue), group enriched (> _5-fold higher expression in the group of tissues compared with other tissues), and tissue enhanced (> _5-fold higher expression in the interrogated tissue compared with the average level in all tissues). We found that the percentage of esophagus-specific genes altered in patients with EoE was at least 2-fold higher than that of genes from other organ-specific transcriptomes (Fig 1, A) .
3 From 297 genes with expression that is specifically enriched in the esophagus relative to other tissues, we found 117 genes overlapping with the EoE transcriptome (designated as Eso-EoE genes), which represent 39% of esophageal signature genes and 7% of genes altered in patients with EoE (Fig 1, B , and see Table E1 in this article's Online Repository at www.jacionline.org). Notably, 89% of Eso-EoE genes (104/117 genes) were significantly downregulated in the esophageal tissue of patients with EoE (Fig 1, B) . Of the genes most highly expressed at the mRNA level in the homeostatic esophagus, 12 genes were expressed approximately 10-to 94-fold higher in the esophagus compared with other interrogated tissues. Of these, only CAPN14 and SERPINB13 were significantly upregulated in patients with EoE (Fig 1, C) . Overall, for the 117 tissue-enriched, tissue-enhanced, and group-enriched genes, only 13 genes were significantly upregulated in patients with EoE (Fig 1, B) . A similar comparison between stomach-specific signature genes and the EG transcriptome 14 identified only 16 overlapping genes, representing 8% of the stomach transcriptome and approximately 1.5% of the transcripts dysregulated in patients with EG (Fig 1, D) .
14 These data suggest that loss of the tissue-specific molecular signature of the esophagus is an integral and specific part of the pathophysiology of EoE.
Functional enrichment analysis of Eso-EoE genes
By performing functional enrichment gene ontology analysis 17 of Eso-EoE genes, we identified endopeptidase inhibitor activity and keratinization as the most profoundly impaired molecular functions and biological processes (P < 10 29 and P < 10 214 , respectively; Fig 2, A and B) . Accordingly, a number of SERPIN-related genes were upregulated (SERPINB2, SERPINB3, SERPINB4, and SERPINB13), whereas genes from the serine protease inhibitor Kazal-type (SPINK) family were downregulated (SPINK5, SPINK7, and SPINK8). Notably, increased expression of SERPINs, specifically SERPINE1 (plasminogen activator inhibitor type I), has been previously reported in patients with EoE and asthma and correlated with disease severity. 19, 20 The downregulated genes also included the differentiation markers KRT6B and involucrin (IVL) and the small proline-rich proteins that comprise members of the EDC previously implicated in EoE pathogenesis. 10 Transglutaminase 1 (TGM1) and TGM3, which are associated with pathogenesis of the rare cornification disease autosomal recessive congenital ichthyosis, 21 were also downregulated in patients with EoE. In line with dysregulation of structural epithelial genes, the most significantly affected human phenotypes were abnormality of keratinization, epidermal thickening, hyperkeratosis, and skin inflammation (Fig 2, C) and a potentially critical role of esophagus-specific proteases in supporting the functional integrity of the epithelial barrier of the esophagus. We next analyzed the properties of Eso-EoE genes on the basis of the common protein domains. The 2 top groups of genes most highly enriched by this analysis were serine protease inhibitors (SERPINs; SERPINB2, SERPINB3, SERPINB4, and SERPINB13) and IL-1 family members (IL36A, IL36RN, IL1A,  and IL1RN ). SERPINs were upregulated (P < 10 27 ), whereas IL-1-related genes were significantly downregulated in patients with EoE (P < 10
25
; Fig 2, D) . Other protein domains enriched in Eso-EoE genes were SPINKs, keratins, members of the arginine deiminase family (PADI1 and PADI3), TGM1, and TGM3 (data not shown).
Eso-EoE genes are regulated during esophageal epithelial differentiation
We aimed to recapitulate the inflammatory process in a cell system in vitro to test whether esophagus-specific changes in transcription were driven by an epithelial rather than tissue-based mixed cellular response. For this purpose, we used ALI culture of an esophageal epithelial cell line, EPC2 cells, that undergoes squamous cell differentiation. 22 Submerged EPC2 cells were grown at low calcium concentration (0.09 mmol/L) and subjected to initial differentiation by exposure to a high concentration of calcium (1.8 mmol/L), followed by terminal differentiation at the ALI with and without IL-13 stimulation (Fig 3, A) . 16 Initial differentiation with high calcium concentrations triggered dramatic transcriptional changes in submerged culture, with 3146 genes changing expression. Overlapping these genes with Eso-EoE genes revealed that 90 (77%) Eso-EoE genes were transcriptionally altered during initial differentiation (Fig 3, B) , with the vast majority being upregulated in the initial differentiation in submerged culture but downregulated in biopsy specimens of patients with EoE (Fig 3, B, heat map) . These results demonstrate the biological relevance of ALI EPC2 cell culture for studying esophageal epithelial differentiation.
IL-13 affects Eso-EoE gene expression
We assessed the effect of IL-13 under conditions of terminal differentiation of epithelial cells at ALI culture (Fig 4, A) . We have previously shown that terminal differentiation of EPC2 cells in the presence of IL-13 leads to altered expression of epithelial differentiation genes. 16 We identified 68 Eso-EoE genes (61% of Eso-EoE genes) affected in ALI culture: expression of 32 genes was altered under all conditions (Fig 4, A, group 1) , 8 genes were altered in response to IL-13 stimulation but not by differentiation (Fig 4, A, group 2) , and 28 genes were affected by the differentiation process but not by IL-13 (Fig 4, A, group 3) . The gene expression pattern of Eso-EoE genes in ALI cultures differentiated in the presence of IL-13 became strikingly similar to that of the biopsy specimens of patients with EoE (32 genes, group 1). For example, CAPN14, SERPINB3, and SERPIN4 were upregulated in both IL-13-treated ALI cultures and biopsy specimens, whereas SPINK5 and genes from IL-1 and small proline-rich protein (SPRR) families were downregulated in both. We observed similar patterns of gene expression in biopsy and in ALI cultures differentiated in the presence of IL-13 independent of whether the genes were significantly affected by the differentiation process (8 genes, group 2). The only exception was SERPINB2, which was downregulated in ALI culture. Epithelial differentiation led to changes in 28 genes that were refractory to IL-13 treatment (group 3). Notably, expression of 16 genes from this group inversely correlated with expression in biopsy specimens: the genes were upregulated in differentiated ALI cultures but downregulated in the disease. We further delineated expression of IL-1 and SERPINB gene families in the ALI system compared with active EoE biopsy specimens. Consistent with other Eso-EoE genes, the expression pattern for these genes was reproduced in ALI culture for 5 of 8 genes, with IL-1 family members downregulated and SERPINs upregulated in IL-13-treated cells (Fig 4, B) .
In light of downregulated expression of IL1A in biopsy specimens and ALI cultures of patients with EoE, we tested whether replenishment of IL-1a would reverse gene expression in IL-13-treated cells subjected to ALI culture. Addition of IL-1a to the cells subjected to ALI either alone or in the presence of IL-13 had no effect on the integrity of the culture, as measured by transepithelial electrical resistance, and did not reverse expression of the prototypic IL-13 target genes CCL26 and SERPINB4 (see Fig E1 in 
org).
Additionally, to determine whether this dysregulation of Eso-EoE genes is a common feature of esophageal disease in general, we assessed the changes in expression of Eso-EoE genes in patients with gastroesophageal reflux disease, which also has epithelial damage and basal zone hyperplasia. None of the 9 Eso-EoE genes tested had dysregulated expression in patients with gastroesophageal reflux disease (Fig 4, C) . 23 Collectively, these results indicate that the downregulation of esophageal signature genes in patients with EoE is likely reflective of an intrinsic defect in esophageal epithelial cell differentiation in response to IL-13.
Quantifying Eso-EoE proteins in esophageal biopsy specimens
We sought to assess levels of expression of Eso-EoE proteins, including structural proteins, proteins related to proteolytic activity, and IL-1 cytokines, in lysates of esophageal biopsy specimens isolated from unaffected control subjects and patients with active EoE (minimum esophageal eosinophil count of at least 15 eosinophils/high-power microscopic field). After functional enrichment analysis, we focused on SERPINB4 and SERPINB13, the structural protein CRNN, and the IL-1 cytokine family member IL-36a. Western blot analysis revealed significant changes in levels of all tested proteins, which paralleled gene expression patterns (Fig 5, A and B) , supporting changes in differentiation, protease activity, and IL-1 cytokines in the esophageal tissue in patients with EoE.
Expression of epithelial differentiation markers in biopsy specimens of patients with active EoE
Expression of genes related to keratinocyte differentiation was most significantly enriched in the Eso-EoE gene set; all of these genes were downregulated in patients with EoE. Therefore we assessed the differentiation status of epithelial tissue in biopsy specimens of patients with active EoE. We applied immunofluorescence to test expression of keratins as common markers of Effect of IL-13 treatment on expression of esophagus-specific Eso-EoE genes at the ALI. A, Venn diagram shows overlap of Eso-EoE genes with transcriptional signature of terminally differentiated ALI in the absence or presence of IL-13. D0 represents the first day and D6 represents the last day of terminal differentiation at ALI (see Fig 3 for details) . Group 1 shows 32 genes altered in biopsy specimens and in the differentiation, as well as CRNN, a member of the EDC specifically expressed in the esophagus (Fig 1, B) . In the biopsy specimens of patients with active EoE, we observed increased expression of KRT5 and KRT14 linked to undifferentiated epithelium and a dramatic loss of KRT4 associated with terminally differentiated tissue (Fig 5, C-E) . 24 The esophagus-specific structural protein CRNN was highly expressed in the suprabasal layers of normal esophageal tissue and downregulated in patients with EoE after expansion of the basal zone of the epithelium (Fig 5,  F) . Furthermore, the increased expression of basal keratins and decreased expression of differentiated keratins does not occur throughout the entire length of the esophagus but rather in areas of active inflammation (compare Fig 5, C-F, middle and bottom  rows) . Collectively, these data are consistent with marked loss of differentiation of esophageal tissue in patients with EoE.
WES analysis of Eso-EoE genes
Because loss of esophagus-specific genes appeared to be a hallmark of EoE, we reasoned that the disease might be associated with an increased burden of rare damaging mutations in Eso-EoE genes. To test this hypothesis, we performed WES of 33 unrelated patients with EoE to identify variants with the potential to alter the biological function of any of the proteins in the list of the 117 EsoEoE genes. We only considered rare variants (<1% minor allele frequency based on public databases) that passed a number of quality control measurements 18 and altered the amino acid sequence (non-synonymous, gaining or losing a stop codon, altering the open reading frame, disrupting the initiation methionine codon, or altering splicing). We identified 39 variants that were located in 18 genes that met these criteria (Table I) . None of the patients had more than 1 rare variant in any particular gene. In addition, we assessed the number of genes with rare variants present in individual patients with EoE. Using the rare variants in Table I , we identified 12 cases carrying only 1 gene, 7 cases carrying 2 genes, and 6 cases carrying 3 genes (data not shown). Among the genes identified as mutated in patients with EoE were those of the protease inhibitors SERPINB3 and SPINK5, CAPN14, and the structural protein KRT6B. Interestingly, mutations in a multisubunit chloride channel gamma-aminobutyric acid A receptor, pi (GABRP), which was primarily studied in the central nervous system, were identified in 4 of 33 patients with EoE. Notably, functional enrichment analysis of these genes 17 identified the most significant molecular function as serine-type endopeptidase inhibitor activity (P 5 8.6 3 10 25 ) and biological processes involved in epidermal cell differentiation (P 5 1.2 3 10
25
).
To test whether the number of mutations correlated with disease severity, we analyzed the number of eosinophils per high-power field in biopsy specimens of patients with different numbers of variants. We were unable to stratify patients with EoE based on the number of variants, probably because of the small number of patients in the groups (data not shown). Collectively, the WES data supported the view that there is a key role for esophagus-specific genes in esophageal differentiation and EoE pathogenesis.
DISCUSSION
Herein we tested the hypothesis that dysregulation of esophagus-specific genes is an integral part of EoE pathogenesis. By comparing the esophageal gene signature with the transcriptome of the esophagus of patients with EoE, 3 we identified that approximately 39% of esophageal genes were altered in patients with EoE (designated Eso-EoE genes); the vast majority of these genes were downregulated in patients with this disease. Functional enrichment analysis of Eso-EoE genes revealed major alterations in keratinization and differentiation, protease-related activities, and IL-1-related genes. We observed that the expression pattern of Eso-EoE genes from biopsy specimens of patients with active EoE and in ALI cultures differentiated in the presence of IL-13 were remarkably similar, providing evidence that loss of esophageal differentiation does not merely reflect a change in the cellular constituents or expansion of the basal epithelial zone. Exposure of epithelial cells to IL-13 led to transcriptional and morphological changes in the epithelium often observed in patients with allergic inflammation, including induction of eotaxin and loss of epithelial integrity. 2, 4, 10, 25, 26 In this regard our data reinforce the role of IL-13 as a molecular driver of EoE, which is consistent with recent findings from anti-IL-13 treatment of EoE, which affected tissue differentiation, as demonstrated by normalized expression of desmoglein-1 (DSG1), KRT14, and KRT16 and tissue-remodeling genes, such as periostin. 27 Although IL-13 is considered critical for EoE pathogenesis, a number of other cytokines and chemokines have been implicated in the disease responses. 28 These molecules, such as the proinflammatory cytokine TNF-a, likely contribute at least in part to EoE pathogenesis by altering the expression of esophagus-specific genes. 29 Inflammation-driven epithelial responses, such as impaired barrier function, are common for epithelia of different origin and constitute a fundamental property of allergic inflammation. 4, 30, 31 ALI in the presence and absence of IL-13. Group 2 shows 8 genes with altered expression in biopsy specimens and in the presence of IL-13 during ALI (D6 vs D6 1 IL-13). Group 3 shows 28 genes with altered expression in biopsy specimens and by ALI differentiation but was not affected by IL-13 (D6 vs  D0) . B, Heat map shows a log 2 fold change in expression of genes from the IL-1 and SERPINB gene families in biopsy specimens and ALI culture from patients with EoE at the indicated conditions. Orange color represents increased expression of SERPIN genes in biopsy specimens from patients with EoE. For  Fig 4, A and B , the heat maps show the log 2 fold change in expression of genes from indicated groups. For all heat maps, the EoE biopsy specimen represents the expression level of the indicated genes in the EoE transcriptome compared with that in unaffected subjects. Clustering was performed by using Euclidean distance and average linkage parameters. Yellow and blue colors correspond to increased or decreased expression, respectively, and black color indicates a nonsignificant change compared with control subjects. C, Expression level of indicated Eso-EoE genes after the EoE diagnostic panel analysis 23 was assessed by using RT-PCR in control subjects (Ctrl), patients with active EoE (EoE), and patients with gastroesophageal reflux disease (GERD). Each dot represents an individual biopsy specimen, and expression was normalized to GAPDH. Error bars represent the SEM of the mean relative expression. *P < .05, **P < .01, and ***P < .001, 1-way ANOVA. ns, Not significant. = J ALLERGY CLIN IMMUNOL VOLUME 140, NUMBER 3 This is supported by a GWAS, which identified genetic association of epithelial cell genes, including TSLP/WDR36, IL33, and its receptor ST2 (IL1RL1), with atopic sensitization and various allergic diseases. 32 The GWAS identified filaggrin, a skin tissue-enriched gene, as strongly genetically associated with atopic dermatitis. 33, 34 In the case of EoE, a recent GWAS identified genetic association with the esophagus-specific gene CAPN14.
11 Analysis of genes within 25 kb of variants with a combined association P value of less than 1 3 10 24 revealed 2 additional esophagus-specific genes: sodium channel, non-voltage-gated 1 b subunit (SCNN1B) and short-chain dehydrogenase/reductase family 9C, member 7 (SDR9C7). Notably, differential expression of these genes was the part of the signature that was sufficient to separate control subjects from patients with EoE. 11 By identifying rare mutations in 18 Eso-EoE genes by WES analysis, including CAPN14, we provide additional supportive biological relevance for the role of esophagus-specific genes in the pathogenesis of EoE.
Furthermore, functional analysis of Eso-EoE genes, as well as mutated Eso-EoE genes, has identified protease-related activity as a putative operational pathway in disease pathogenesis. Among the genes most significantly altered in patients with and active EoE (EoE) samples (n 5 3 biopsy specimens). Red and green arrows point to the bands corresponding to analyzed proteins; molecular weight markers are shown on the right. B, Graphs show relative expression of the indicated proteins normalized to the loading control (HSP90) by using Western blotting (n 5 5-10 samples for each group). Error bars represent the SEM of the mean relative expression. *P < .05 and **P < .01, Mann-Whitney test. C-F, Immunofluorescence of distal esophageal biopsy specimens from control subjects (Ctrl, top row) or patients with active EoE (EoE Inflamed, middle row) or proximal esophageal biopsy specimens from regions that do not have active inflammation from patients with active EoE (EoE Non-inflamed, bottom row). Staining with the nuclear dye DAPI or with an antibody directed against the indicated differentiation marker (KRT5, KRT14, KRT4, or CRNN) are indicated by blue or green, respectively. White broken line indicates basal membrane. Scale bar 5 100 mm.
those for the SERPINBs and SPINKs, supporting a recently proposed critical role for the balance in serine protease activity in EoE pathogenesis. 35 An unexpected finding in our study was delineating IL-1 family members as esophagus-specific gene products. IL-36a directly activates naive CD4 cells, inducing IL-2 secretion and thereby priming a T H 1 inflammatory response. 36 Given the potential role of IL-36a in the pathogenesis of inflammation, 37 we assessed IL-36a protein levels in biopsy specimens of patients with active EoE and control subjects (Fig 5) . We found that IL-36a protein expression was significantly decreased in patients with EoE, implicating IL-36a in balancing T H 1/T H 2 responses in the disease. We have previously reported increased levels of IL-1a protein in the blood and decreased esophageal expression of IL1RN mRNA in patients with active EoE. 28 Additionally, decreased expression of IL-1a and IL-1 receptor a has been observed in biopsy specimens from patients with active EoE. 38, 39 Collectively, these data implicate IL-1-related genes in the pathogenesis of EoE, presumably through modulating a balance of inflammatory and allergic signals in the context of esophageal tissue. 40 A specific feature of the IL-1 family of cytokines is a requirement for N-terminal cleavage for enhanced biological activity. 37 It has been reported that cysteine and serine proteases, such as calpains and elastase, can directly cleave IL-1 cytokines. 41 Divergent expression of SERPINs and IL-1 cytokines in biopsy specimens from patients with EoE suggests a functional link between proteolytic activity and IL-1-related cytokine activity in disease pathogenesis. Taken together, our data implicate IL-1-related proteins in disease progression. We speculate that IL-1 family members selectively expressed in the esophagus provide homeostatic regulation of the surface stimuli encountered by esophageal mucosa.
The finding that the esophagus normally expresses IL-1 family members, as well as protease inhibitors that likely curtail inflammation, suggests a previously unappreciated role for basal innate immunity in the esophagus. We propose that the esophagus is normally equipped with these processes to respond successfully to its robust exposure to a variety of ingested foreign substances (eg, food). An imbalance of esophageal homeostatic processes can contribute to the development of various diseases of the upper gastrointestinal tract and perhaps lead to systemic antigen sensitization, especially in view of the impaired barrier function that develops when epithelial differentiation is lost. 4, 5 Our findings expand our understanding of the propagation of allergic inflammation on the level of tissue molecular identity and suggest that genetic profiling and assessing expression levels of esophagus-specific genes might have diagnostic and prognostic value. We propose that the altered esophageal transcriptome driven by organ-specific imbalanced protease activity leads to profound loss of esophageal differentiation, which constitutes an integral process in allergic inflammation specific to the esophagus (Fig 6) .
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Key messages
d Esophagus-specific genes are enriched in IL-1 family members and a series of proteases and protease inhibitors.
d Esophagus-specific transcripts have altered expression in patients with EoE, with nearly all (approximately 90%) being downregulated.
d EoE involves a loss of tissue differentiation (eg, loss of tissue identity).
d Organ-specific, imbalanced protease activity is an integral process in allergic inflammation specific to the esophagus. 
